Cargando…
Telomere-based risk models for the early diagnosis of clinically significant prostate cancer
BACKGROUND: The objective of this study was to explore telomere-associated variables (TAV) as complementary biomarkers in the early diagnosis of prostate cancer (PCa), analyzing their application in risk models for significant PCa (Gleason score > 6). METHODS: As part of a larger prospective long...
Autores principales: | Rubio Galisteo, Juan Manuel, Fernández, Luis, Gómez Gómez, Enrique, de Pedro, Nuria, Cano Castiñeira, Roque, Pedregosa, Ana Blanca, Guler, Ipek, Carrasco Valiente, Julia, Esteban, Laura, González, Sheila, Castelló, Nila, Otero, Lissette, García, Jorge, Segovia, Enrique, Requena Tapia, María José, Najarro, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012205/ https://www.ncbi.nlm.nih.gov/pubmed/32367011 http://dx.doi.org/10.1038/s41391-020-0232-4 |
Ejemplares similares
-
Analytical Validation of Telomere Analysis Technology® for the High-Throughput Analysis of Multiple Telomere-Associated Variables
por: de Pedro, Nuria, et al.
Publicado: (2020) -
Perineostomy: the last oportunity
por: Lopez, Juan Carlos Regueiro, et al.
Publicado: (2015) -
CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer
por: Frantzi, Maria, et al.
Publicado: (2019) -
Clinical association of metabolic syndrome, C‐reactive protein and testosterone levels with clinically significant prostate cancer
por: Gómez‐Gómez, Enrique, et al.
Publicado: (2018) -
Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination
por: Frantzi, Maria, et al.
Publicado: (2023)